Facebook Instagram Pinterest Reddit Tumblr X Youtube

Home
About
News
Events
Shop
Directory
Contact Us

Search

Sign in

Welcome! Log into your account

your username

your password

Forgot your password? Get help

Password recovery

Recover your password

your email

A password will be e-mailed to you.

Home
About
News
Events
Shop
Directory
Contact Us

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

By

-

April 24, 2026

10

Post Content

Previous articleErica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

Next articleMartha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

RELATED ARTICLES MORE FROM AUTHOR

May 2026 Psychedelic Bill Roundup

Utah’s Quiet Revolution: Why HB 390 May Be the Most Significant Psychedelic Legislation of 2026

Field Notes #2: Dispatches from London and the Netherlands

Newsletter

EDITOR PICKS

May 2026 Psychedelic Bill Roundup

Utah’s Quiet Revolution: Why HB 390 May Be the Most Significant...

Field Notes #2: Dispatches from London and the Netherlands

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

FOLLOW US

Facebook Instagram Pinterest Reddit Tumblr X Youtube

©

MORE STORIES

May 2026 Psychedelic Bill Roundup